Trending
Recently Published
All Articles
Virtual reality opens doors for older people to build closer connections in real life24.12.2025Like many retirement communities, The Terraces serves as a tranquil refuge for a nucleus of older people who no longer can travel to faraway places or engage in bold adventures. The selection of VR programming was curated by Rendever, a company that has turned a sometimes isolating form of technology into a catalyst for better cognition and social connections in 800 retirement communities in the United States and Canada. The Rendever technology can also be used to virtually take older adults b
Well known SUVs With Low Energy Utilization In 202405.06.2024As ecological worries develop, numerous shoppers are searching for vehicles that offer both exhibition and eco-friendliness. The SUV market
Flu season is ramping up, and some experts are "pretty worried"22.12.2025Doctors and scientists say this year's influenza season could be tougher than usual, with a new version of the flu virus, called H3N2, spreading quickly.
Bayer reports positive results for blood thinner after 2023 setback23.11.2025BERLIN () -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate. In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Surveys of 6 Hot Savvy Beds05.06.2024The universe of savvy home innovation has extended to incorporate our rooms, changing the manner in which we lay down with creative shrewd
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials02.12.2025SAN DIEGO Dec 2 (Reuters) - Novo Nordisk in 2020 launched pivotal trials of its GLP-1 drug semaglutide in Alzheimer's patients based on studies in humans, animals and real-world findings, a top company executive said on Tuesday, acknowledging criticism that Novo's studies had design flaws. Although the trials failed to show statistically significant slowing of cognitive decline in patients given the drug, "we still think it was the right decision.
Bismuth’s haredi draft bill won’t change enlistment, IDI expert tells 'Post'30.11.2025An Israel Democracy Institute expert warns that MK Boaz Bismuth’s haredi draft offers no real enforcement and will not improve enlistment rates. Nothing will change from MK Boaz Bismuth’s (Likud) bill to enforce haredi (ultra-Orthodox) conscription to the IDF, which is currently being advanced merely for the government, “to stall for time,” Shlomit Ravitsky Tur-Paz of the Israel Democracy Institute told The Jerusalem Post on Sunday.
AI is providing emotional support for employees – but is it a valuable tool or privacy threat?20.11.2025People are increasingly using AI chatbots for emotional and psychological support. Now, companies are using it to support employees – raising a host of issues.















